TW200602031A - Antiinflammatory and pain-relieving agent for external, use - Google Patents

Antiinflammatory and pain-relieving agent for external, use

Info

Publication number
TW200602031A
TW200602031A TW094119781A TW94119781A TW200602031A TW 200602031 A TW200602031 A TW 200602031A TW 094119781 A TW094119781 A TW 094119781A TW 94119781 A TW94119781 A TW 94119781A TW 200602031 A TW200602031 A TW 200602031A
Authority
TW
Taiwan
Prior art keywords
pain
antiflammatory
relieving
agent
relieving agent
Prior art date
Application number
TW094119781A
Other languages
English (en)
Other versions
TWI341212B (en
Inventor
Youichi Kawamura
Yusuke Honda
Original Assignee
Hisamitsu Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisamitsu Pharmaceutical Co filed Critical Hisamitsu Pharmaceutical Co
Publication of TW200602031A publication Critical patent/TW200602031A/zh
Application granted granted Critical
Publication of TWI341212B publication Critical patent/TWI341212B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7076—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
TW094119781A 2004-06-15 2005-06-15 Antiinflammatory and pain-relieving agent for external use TWI341212B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2004176722 2004-06-15

Publications (2)

Publication Number Publication Date
TW200602031A true TW200602031A (en) 2006-01-16
TWI341212B TWI341212B (en) 2011-05-01

Family

ID=35509462

Family Applications (1)

Application Number Title Priority Date Filing Date
TW094119781A TWI341212B (en) 2004-06-15 2005-06-15 Antiinflammatory and pain-relieving agent for external use

Country Status (6)

Country Link
US (2) US7928144B2 (zh)
EP (1) EP1767218B1 (zh)
JP (1) JP4990617B2 (zh)
ES (1) ES2590258T3 (zh)
TW (1) TWI341212B (zh)
WO (1) WO2005123136A1 (zh)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2370511T3 (es) * 2005-02-25 2011-12-19 Hisamitsu Pharmaceutical Co., Inc. Preparado transdérmico para uso externo que contiene un agente analgésico/antiinflamatorio no esteroideo.
BRPI0621386B8 (pt) * 2006-03-08 2021-07-13 Nihon Nihyaku Co Ltd composição farmacêutica para o uso externo
NZ571819A (en) 2006-03-08 2011-04-29 Nihon Nohyaku Co Ltd External pharmaceutical composition comprising luliconazole and either N-methyl-2-pyrrolidone, propylene carbonate or crotamiton
JP5184342B2 (ja) * 2006-03-08 2013-04-17 日本農薬株式会社 外用の医薬組成物
JP5078303B2 (ja) * 2006-09-15 2012-11-21 東光薬品工業株式会社 消炎鎮痛クリーム製剤及びその製造方法
CN101808638B (zh) 2007-09-05 2012-07-25 宝丽制药股份有限公司 抗真菌组合物
CN101808639B (zh) 2007-09-05 2012-12-05 宝丽制药股份有限公司 抗真菌医药组合物
KR20100075475A (ko) 2007-09-05 2010-07-02 가부시키가이샤 폴라 파마 의약 조성물
JP5301205B2 (ja) * 2008-05-28 2013-09-25 東興薬品工業株式会社 ゲル軟膏組成物
JP2010120912A (ja) * 2008-11-21 2010-06-03 Lead Chemical Co Ltd ５−メチル−１−フェニル−２−（１ｈ）−ピリドン含有貼付剤
KR101409789B1 (ko) 2009-04-09 2014-06-19 니혼노야쿠가부시키가이샤 항진균성 약제학적 조성물
WO2010117091A2 (en) 2009-04-09 2010-10-14 Pola Pharma Inc. Antimycotic pharmaceutical composition
KR101754697B1 (ko) 2009-08-25 2017-07-06 가부시키가이샤 폴라 파마 항진균성 약제학적 조성물
JP5430601B2 (ja) * 2011-04-01 2014-03-05 マルホ株式会社 非エアゾール式フォーム剤用組成物
WO2013112416A1 (en) * 2012-01-26 2013-08-01 Product And Technology Partners Llc Clear solid sticks with solubilized pharmaceutical agents
US8822537B2 (en) * 2012-09-27 2014-09-02 Achelios Therapeutics, Inc. Topical ketoprofen composition
MX352771B (es) 2012-12-20 2017-12-07 Unilever Nv Mezclas eutecticas en composiciones de cuidado personal.
CN105960234A (zh) * 2014-02-27 2016-09-21 久光制药株式会社 含有酮洛芬的巴布剂
CN105434350A (zh) * 2015-12-24 2016-03-30 中国药科大学 一种双氯芬酸钠冰冻复乳经皮给药制剂及其制备方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60155111A (ja) * 1983-10-20 1985-08-15 Hisamitsu Pharmaceut Co Inc 安定なケトプロフェン含有外用経皮製剤
US4954332A (en) * 1987-10-22 1990-09-04 The Procter & Gamble Company Photoprotection compositions comprising tocopherol sorbate and an anti-inflammatory agent
JPH05178763A (ja) * 1991-02-19 1993-07-20 Nippon Saafuakutanto Kogyo Kk 難溶解性薬物溶解剤組成物
JPH058169A (ja) 1991-07-02 1993-01-19 Daido Steel Co Ltd 湿式磁気研磨方法および研磨材
EP0696319B1 (en) * 1993-04-30 2003-01-29 Novozymes A/S An enzyme exhibiting pectin methylesterase activity
JP3661706B2 (ja) 1993-10-28 2005-06-22 三省製薬株式会社 皮膚外用剤
US5891846A (en) * 1994-02-17 1999-04-06 Shiseido Company, Ltd. Cyclosporin-containing emulsion composition
US5830827A (en) * 1995-09-21 1998-11-03 Ishihara Sangyo Kaisha, Ltd. Granular herbicidal composition comprising flazasulfuron and a sulfosuccinate or benzoate stabilizer
JPH09151108A (ja) 1995-11-30 1997-06-10 Kose Corp 油中水型乳化化粧料
JP3537622B2 (ja) 1996-02-26 2004-06-14 株式会社資生堂 紫外線吸収性組成物
JP2000136122A (ja) 1998-10-28 2000-05-16 Kose Corp 皮膚外用剤
FR2804024B1 (fr) * 2000-01-21 2002-09-13 Menarini France Nouvelles compositions pharmaceutiques a action anti- inflammatoire et leur procede de preparation
WO2001068061A1 (fr) 2000-03-17 2001-09-20 Hisamitsu Pharmaceutical Co., Inc. Preparation adhesive protegeant des uv
EP1234573B1 (fr) 2001-02-22 2005-07-27 Menarini France S.A. Compositions pharmaceutiques à action anti-inflammatoire comprenant du kétoprofène
JP4048418B2 (ja) * 2002-04-24 2008-02-20 東洋紡績株式会社 延伸ポリエステルフィルム及び、その製造方法
US20040220259A1 (en) * 2003-04-04 2004-11-04 Yu Ruey J. Topical treatment of dermatological disorders associated with reactive or dilated blood vessels
US6927206B2 (en) * 2003-06-06 2005-08-09 Procyte Corporation Compositions and methods for treatment of rosacea
TWI337086B (en) * 2003-09-03 2011-02-11 Hisamitsu Pharmaceutical Co Transdermal formulation containing nonsteroidal antiinflammatory drug

Also Published As

Publication number Publication date
ES2590258T3 (es) 2016-11-21
EP1767218B1 (en) 2016-08-10
US20110028555A1 (en) 2011-02-03
EP1767218A1 (en) 2007-03-28
WO2005123136A1 (ja) 2005-12-29
US20080031835A1 (en) 2008-02-07
US7928144B2 (en) 2011-04-19
TWI341212B (en) 2011-05-01
JPWO2005123136A1 (ja) 2008-04-10
US8877813B2 (en) 2014-11-04
EP1767218A4 (en) 2010-11-03
JP4990617B2 (ja) 2012-08-01

Similar Documents

Publication Publication Date Title
TW200602031A (en) Antiinflammatory and pain-relieving agent for external, use
ATE550031T1 (de) Zusammensetzungen und verfahren für die lipomodellierung
TW200716191A (en) Improved cosmetic composition
SG151303A1 (en) New compounds for the inhibition of angiogenesis and use thereof
BRPI0513750A (pt) 2-fenilamino-benzamidas-5-substituìdas como inibidoras de mek
HRP20050781B1 (hr) Metode i farmaceutske mješavine za pouzdano postizanje prihvatljivih razina testosterona u serumu
BRPI0518228A (pt) inibidores de cinesina mitótica e métodos de uso destes
IL180600A0 (en) Compositions and methods of use for treatment of mammalian diseases
WO2006093348A3 (en) Method and composition for treating peripheral vascular diseases
ATE456369T1 (de) Flibanserin zur behandlung von harninkontinenz und assoziierten erkrankungen
UY27872A1 (es) Inhibidores de caspasa y usos de los mismos.
HK1124546A1 (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of mania and bipolar disorder
MY148459A (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of depression
MXPA06012566A (es) Tratamiento de enfermedades infecciosas.
WO2007056352A3 (en) Compositions and methods for controlling tissue factor signaling specificity
HK1205531A1 (zh) 間葉幹細胞及其用法
MX366496B (es) Metodos para preparar composiciones farmaceuticas que comprenden acetato de eslicarbazepina y metodos de uso.
HK1112721A1 (en) Tissue disruption treatment and composition for use thereof
ATE531703T1 (de) Benzochromenderivate
MXPA05013226A (es) Carbamatos de piperidina sustituidos, para el uso como inhibidores de la lipasa sensible a hormonas.
MXPA05010416A (es) Combinacion de substancias activas de aceites minerales que contienen acidos grasos (3 con extractos vegetales que contengan polifenoles y su uso.
DK2155886T3 (da) Kosmetisk anvendelse af tyrosinaseinhibitorer
ATE477786T1 (de) Zusammensetzung enthalend wortmannin und ihre topische verwendung zur haarwuchshemmung
TW200512003A (en) Enhanced method of treatment of growth disorders
EA200702479A1 (ru) Активная композиция для лечения и профилактики расстройств, связанных с нарушением работы биологических часов